Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Neoadjuvant chemotherapy (NACT) is frequently used in patients with early breast cancer. Randomized controlled trials have demonstrated similar survival after NACT or adjuvant chemotherapy (ACT). However, certain subtypes may benefit more when NACT contains regimes leading to high rates of pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortmann, O., Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984341/
https://www.ncbi.nlm.nih.gov/pubmed/35380257
http://dx.doi.org/10.1007/s00432-022-03938-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984341/
https://www.ncbi.nlm.nih.gov/pubmed/35380257
http://dx.doi.org/10.1007/s00432-022-03938-x

Ejemplares similares